(Q53379868)

13 May 2018

title

Utility assessment among patients with dry eye disease. (English)

1 reference

13 May 2018

0 references

6

Walton Sumner

1 reference

13 May 2018

author name string

Rhett M Schiffman

1

1 reference

13 May 2018

John G Walt

2

1 reference

13 May 2018

Gordon Jacobsen

3

1 reference

13 May 2018

John J Doyle

4

1 reference

13 May 2018

Gary Lebovics

5

1 reference

13 May 2018

publication date

1 July 2003

1 reference

13 May 2018

published in

Ophthalmology

1 reference

13 May 2018

volume

110

1 reference

13 May 2018

issue

7

1 reference

13 May 2018

page(s)

1412-1419

1 reference

13 May 2018

Prevalence of dry eye among the elderly

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Reliability and validity of the Ocular Surface Disease Index

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Development of the 25-item National Eye Institute Visual Function Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Utility-based estimates of the relative morbidity of visual impairment and angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Utility values and age-related macular degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Utility values associated with blindness in an adult population

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Utility values and diabetic retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

A note on QALYs, time tradeoff, and discounting.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

1 reference

7 January 2021

Assessing the preferences of patients with psoriasis. A quantitative, utility approach

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Variation in patient utilities for outcomes of the management of chronic stable angina. Implications for clinical practice guidelines. Ischemic Heart Disease Patient Outcomes Research Team

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Assessment of patient preferences among men with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

The importance of patient preferences for comorbidities in cost-effectiveness analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

A cost-utility analysis of the home parenteral nutrition program at Toronto General Hospital: 1970-1982

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Utilities and quality-adjusted life years

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Preference values for visual states in patients planning to undergo cataract surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

Cost utility analysis: what should be measured?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2803%2900462-7

7 January 2021

10.1016/S0161-6420(03)00462-7

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018